Kristin S. Ricci, MD

Opinion

A new era of TTP treatment

Author:: Kristin S. Ricci, MD

Publish date: March 18, 2019

Many questions remain following the FDA’s approval of caplacizumab, specifically, which patients should receive it. The high cost of the drug is al...